Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             43 results found
no title author magazine year volume issue page(s) type
1 Adapted physical activity and diet (APAD) during adjuvant breast cancer therapy: Design and implementation of a prospective randomized controlled trial Carayol, Marion
 2013
 36 2 p. 531-543
13 p.
 article
2 Adaptive enrichment with subpopulation selection at interim: Methodologies, applications and design considerations Wang, Sue-Jane
 2013
 36 2 p. 673-681
9 p.
 article
3 An industry statistician's perspective on PHC drug development Fridlyand, Jane
 2013
 36 2 p. 624-635
12 p.
 article
4 A review of phase II trial designs for initial marker validation Mandrekar, Sumithra J.
 2013
 36 2 p. 597-604
8 p.
 article
5 A telephone intervention for dementia caregivers: Background, design, and baseline characteristics Tremont, Geoffrey
 2013
 36 2 p. 338-347
10 p.
 article
6 A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials Zhong, Wei
 2013
 36 2 p. 587-596
10 p.
 article
7 A unifying framework for standard and covariate-adaptive randomization procedures based on minimizing suitable imbalance functions Berger, Vance W.
 2013
 36 2 p. 527-530
4 p.
 article
8 Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpoints Gu, Xuemin
 2013
 36 2 p. 642-650
9 p.
 article
9 Childhood Obesity Prevention and Treatment Research (COPTR): Interventions addressing multiple influences in childhood and adolescent obesity Pratt, Charlotte A.
 2013
 36 2 p. 406-413
8 p.
 article
10 Clinical trials in “emerging markets”: Regulatory considerations and other factors Singh, Romi
 2013
 36 2 p. 711-718
8 p.
 article
11 Clinical trials in the Middle East and North Africa (MENA) Region: Grandstanding or Grandeur? Nair, Satish Chandrasekhar
 2013
 36 2 p. 704-710
7 p.
 article
12 Conducting randomised controlled trials across countries with disparate levels of socio-economic development: The experience of the Asia-Pacific Hepatocellular Carcinoma Trials Group Kong, Nicole H.Y.
 2013
 36 2 p. 682-686
5 p.
 article
13 Consistency assessment with global and bridging development strategies in emerging markets Li, Gang
 2013
 36 2 p. 687-696
10 p.
 article
14 Design and baseline data from the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized controlled trial Huffman, Jeff C.
 2013
 36 2 p. 488-501
14 p.
 article
15 Design and conduct of ‘Xtreme Alps’: A double-blind, randomised controlled study of the effects of dietary nitrate supplementation on acclimatisation to high altitude Martin, Daniel S.
 2013
 36 2 p. 450-459
10 p.
 article
16 Design features of the Diabetes and Periodontal Therapy Trial (DPTT): A multicenter randomized single-masked clinical trial testing the effect of nonsurgical periodontal therapy on glycosylated hemoglobin (HbA1c) levels in subjects with type 2 diabetes and chronic periodontitis Engebretson, S.
 2013
 36 2 p. 515-526
12 p.
 article
17 Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: Methods and participant characteristics for the Heart to Health study Sheridan, Stacey L.
 2013
 36 2 p. 394-405
12 p.
 article
18 Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods Jeon, Sangchoon
 2013
 36 2 p. 414-420
7 p.
 article
19 Editorial Board 2013
 36 2 p. iii-
1 p.
 article
20 Enhancing exposure therapy for PTSD with yohimbine HCL: Protocol for a double-blind, randomized controlled study implementing subjective and objective measures of treatment outcome Wangelin, Bethany C.
 2013
 36 2 p. 319-326
8 p.
 article
21 Family, community and clinic collaboration to treat overweight and obese children: Stanford GOALS—A randomized controlled trial of a three-year, multi-component, multi-level, multi-setting intervention Robinson, Thomas N.
 2013
 36 2 p. 421-435
15 p.
 article
22 Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research Lai, Tze Leung
 2013
 36 2 p. 651-663
13 p.
 article
23 Growing Right Onto Wellness (GROW): A family-centered, community-based obesity prevention randomized controlled trial for preschool child–parent pairs Po'e, Eli K.
 2013
 36 2 p. 436-449
14 p.
 article
24 IMPACT: A multi-level family and school intervention targeting obesity in urban youth Moore, Shirley M.
 2013
 36 2 p. 574-586
13 p.
 article
25 Improving depression treatment for women: Integrating a collaborative care depression intervention into OB-GYN care LaRocco-Cockburn, Anna
 2013
 36 2 p. 362-370
9 p.
 article
26 NET-Works: Linking families, communities and primary care to prevent obesity in preschool-age children Sherwood, Nancy E.
 2013
 36 2 p. 544-554
11 p.
 article
27 New paradigm for drug developments—From emerging market statistical perspective Quan, Hui
 2013
 36 2 p. 697-703
7 p.
 article
28 Overfitting in prediction models – Is it a problem only in high dimensions? Subramanian, Jyothi
 2013
 36 2 p. 636-641
6 p.
 article
29 Personalized medicine in Alzheimer's disease and depression Souslova, Tatiana
 2013
 36 2 p. 616-623
8 p.
 article
30 Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: The PROPEL Study Domanchuk, Kathryn
 2013
 36 2 p. 502-509
8 p.
 article
31 Pro-HEART — A randomized clinical trial to test the effectiveness of a high protein diet targeting obese individuals with heart failure: Rationale, design and baseline characteristics Motie, Marjan
 2013
 36 2 p. 371-381
11 p.
 article
32 Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: The early intervention in cystic fibrosis exacerbation (eICE) trial Lechtzin, N.
 2013
 36 2 p. 460-469
10 p.
 article
33 Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers Sonnad, Seema S.
 2013
 36 2 p. 356-361
6 p.
 article
34 Sample size and threshold estimation for clinical trials with predictive biomarkers Mackey, Howard M.
 2013
 36 2 p. 664-672
9 p.
 article
35 Strategies to Avoid Returning to Smoking (STARTS): A randomized controlled trial of postpartum smoking relapse prevention interventions Levine, Michele D.
 2013
 36 2 p. 565-573
9 p.
 article
36 Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial 2013
 36 2 p. 555-564
10 p.
 article
37 Supportive monitoring and disease management through the internet: An internet-delivered intervention strategy for recurrent depression Kordy, Hans
 2013
 36 2 p. 327-337
11 p.
 article
38 The Cooperative Lifestyle Intervention Program-II (CLIP-II): Design and methods Marsh, Anthony P.
 2013
 36 2 p. 382-393
12 p.
 article
39 The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): Study protocol for a randomised controlled trial Morley, K.C.
 2013
 36 2 p. 348-355
8 p.
 article
40 The ethics of placebo-controlled trials: Methodological justifications Millum, Joseph
 2013
 36 2 p. 510-514
5 p.
 article
41 The evolving landscape of therapeutic drug development for hepatocellular carcinoma Chong, Dawn Qingqing
 2013
 36 2 p. 605-615
11 p.
 article
42 The Midwest Exercise Trial for the Prevention of Weight Regain: MET POWeR Szabo, Amanda N.
 2013
 36 2 p. 470-478
9 p.
 article
43 The South Asian Heart Lifestyle Intervention (SAHELI) study to improve cardiovascular risk factors in a community setting: Design and methods Kandula, Namratha R.
 2013
 36 2 p. 479-487
9 p.
 article
                             43 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands